West Pharmaceutical Services, Inc. (WST)
266.96
+0.89
(+0.33%)
USD |
NYSE |
Dec 10, 16:00
267.37
+0.41
(+0.15%)
Pre-Market: 20:00
West Pharmaceutical Services Cash from Investing (Quarterly): -63.30M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -502.00M |
| Envista Holdings Corp. | -9.70M |
| Intuitive Surgical, Inc. | 401.00M |
| Becton, Dickinson & Co. | -494.00M |
| ResMed, Inc. | -52.58M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 197.20M |
| Cash from Financing (Quarterly) | -11.50M |
| Free Cash Flow | 379.10M |
| Free Cash Flow Per Share (Quarterly) | 1.844 |
| Free Cash Flow to Equity (Quarterly) | 139.10M |
| Free Cash Flow to Firm (Quarterly) | 133.98M |
| Free Cash Flow Yield | 1.95% |